Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
Globe Newswire•12/08/2026•16:05 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.